Clinical Trials Directory

Trials / Completed

CompletedNCT01925066

Aerosolized Vancomycin in Methicillin-Resistant Staphylococcus Aureus Pneumonia Under Mechanical Ventilation

Optimal Two-Stage Phase 2 Study of Efficacy and Pharmacokinetics of Aerosolized Vancomycin in Methicillin-Resistant Staphylococcus Aureus Pneumonia Under Mechanical Ventilation

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether aerosolized vancomycin is effective in the treatment of methicillin-resistant staphylococcus aureus pneumonia under mechanical ventilation.

Conditions

Interventions

TypeNameDescription
DRUGVancomycin

Timeline

Start date
2013-08-01
Primary completion
2017-12-01
Completion
2017-12-01
First posted
2013-08-19
Last updated
2019-04-23

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01925066. Inclusion in this directory is not an endorsement.

Aerosolized Vancomycin in Methicillin-Resistant Staphylococcus Aureus Pneumonia Under Mechanical Ventilation (NCT01925066) · Clinical Trials Directory